Connection

KATHERINE A NAFF to Receptor, ErbB-2

This is a "connection" page, showing publications KATHERINE A NAFF has written about Receptor, ErbB-2.
Connection Strength

0.026
  1. Ability to Generate Patient-Derived Breast Cancer Xenografts Is Enhanced in Chemoresistant Disease and Predicts Poor Patient Outcomes. PLoS One. 2015; 10(9):e0136851.
    View in: PubMed
    Score: 0.016
  2. Development of a targeted gene vector platform based on simian adenovirus serotype 24. J Virol. 2010 Oct; 84(19):10087-101.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.